Document Detail

Effectiveness of a 12-month Exercise Program on Physical Performance and Quality of Life of Breast Cancer Survivors.
MedLine Citation:
PMID:  22993332     Owner:  NLM     Status:  In-Data-Review    
PATIENTS AND METHODS: A total of 573 breast cancer survivors were randomized into an exercise or a control group, 12-months after adjuvant treatments. EORTC QLQ-C30 and BR-23 questionnaires were used for evaluation of QoL, FACIT-F for fatigue and the Finnish modified version of Beck's 13-item depression scale (RBDI) for depression. Physical fitness was assessed by a 2-km walking test, and a figure-8 running test and physical activity (PA) by metabolic equivalent (MET) hours per week (MET-h/wk).
RESULTS: Figure-8 running time improved significantly among the patients of the intervention group compared with the controls (p<0.001). No significant between-group differences were observed in 2-km walking time, in PA, EORTC-QLQ-C30, BR-23, FACIT-F or BDI. However, there was a linear relationship between increased PA and improved QoL (p=0.006), irrespective of the intervention.
CONCLUSION: Increase in physical activity was associated with improved QoL, but no effect of the exercise intervention was observed.
Tiina Saarto; Heidi Marika Penttinen; Harri Sievänen; Pirkko-Liisa Kellokumpu-Lehtinen; Liisa Hakamies-Blomqvist; Riku Nikander; Riikka Huovinen; Riitta Luoto; Hannu Kautiainen; Salme Järvenpää; Irja Idman; Meri Utriainen; Leena Vehmanen; Anna-Stina Jääskeläinen; Anneli Elme; Johanna Ruohola; Tiina Palva; Harri Vertio; Matti Rautalahti; Mikael Fogelholm; Carl Blomqvist; Minna-Liisa Luoma
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-09-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3875-84     Citation Subset:  IM    
Department of Oncology, Helsinki University Central Hospital, P.O.Box 180, 00029 HUS, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Expression of CYP2W1: A Prognostic Marker in Colon Cancer.
Next Document:  Chemotherapy Dose-intensity and Survival for Childhood Medulloblastoma.